Atlas Trials

Locally Advanced Urothelial Carcinoma

21 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Locally Advanced Urothelial Carcinoma

RecordFirmDate
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy (NCT04963153)National Cancer Institute (NCI)2022-07-07
Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy (NCT04637594)Alliance for Clinical Trials in Oncology2022-05-27
Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma (NCT05154994)University of Utah2022-01-14
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib (NCT05052372)xCures2021-11-21
Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer (NCT04878029)Emory University2021-07-23
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma (NCT04848519)Emory University2021-05-20
Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors (NCT04007744)Mayo Clinic2020-02-13
Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma (NCT03854474)National Cancer Institute (NCI)2019-11-18
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer (NCT03244384)National Cancer Institute (NCI)2017-11-03

Track Locally Advanced Urothelial Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.